Centuple Global Share Price
35.72-1.87 (-4.97%)
+3.96% past 1 Year
Rubra Medicaments Ltd was Incrporated in the year of 1991. The company is in the business activity of Non-Specialized Wholesale Trade. The company's range of products and services include Traded
Corporate filings & documents
Announcements
Annual Secretariral Compliance Report for the year ended March 31 2026
1 week agoAnnual Secretariral Compliance Report for the year ended March 31 2026
1 week agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve Intimation of board meeting
1 week agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve Intimation of board meeting
1 week agoCompliace certificate under regulation 74 for the quarter ended June 30 2026
1 week agoCompliace certificate under regulation 74 for the quarter ended June 30 2026
1 week agoNewspaper publication
2 weeks agoNewspaper publication
2 weeks agoResignation of statutory auditor
2 weeks agoResignation of statutory auditor
2 weeks agoOutcome of board meeting
3 weeks agoOutcome of board meeting
3 weeks agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To approve the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2026.2. Loan from Director of the Company3. To consider and approve Related Party Transaction for the quarter ending June 30 2026
1 month agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To approve the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2026.2. Loan from Director of the Company3. To consider and approve Related Party Transaction for the quarter ending June 30 2026
1 month agoResignation of Ms. Shruti gupta as Non-executive Independent Director
1 month agoResignation of Ms. Shruti gupta as Non-executive Independent Director
1 month agoClosure of trading window in connection with unaudited financial result for the quarter ended June 30 2026
2 months agoClosure of trading window in connection with unaudited financial result for the quarter ended June 30 2026
2 months agoScrutinizer report of EGM
2 months agoScrutinizer report of EGM
2 months agoOutcome of EGM
2 months agoOutcome of EGM
2 months agoEGM Proceeding
2 months agoEGM Proceeding
2 months agoNewspaper publication
3 months agoNewspaper publication
3 months agoAudited financial result for the quarter and year ended March 31 2026
3 months agoAudited financial result for the quarter and year ended March 31 2026
3 months agoOutcome of Board Meeting
3 months agoOutcome of Board Meeting
3 months agoResignation of Director
3 months agoResignation of Director
3 months agoSubmission of newspaper publication of EGM
3 months agoSubmission of newspaper publication of EGM
3 months agoNotice of EGM
3 months agoNotice of EGM
3 months agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of board meeting
3 months agoOutcome of Board Meeting
3 months agoOutcome of Board Meeting
3 months agoIntimation of board meeting
3 months agoIntimation of board meeting
3 months agoCentuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 inter alia to consider and approve Resignation of Secretarial Auditor and Appointment of New Secretarial Auditor and Calling of EGM
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Checkpoint Trends Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L46307MH1991PLC326598</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>6.73</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Artee Sahu <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Shubham Chaudhary <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Checkpoint Trends Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L46307MH1991PLC326598</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2024-25 25-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>6.73</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2023-24 24-25</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Artee Sahu</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Shubham Chaudhary</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 29/04/2026<br/><br/></div>
4 months agoClarification on Price Movement of Equity Shares
4 months agoThe Exchange has sought clarification from Checkpoint Trends Ltd on April 15 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoCompliance certificate for the quarter ended March 31 2026
4 months agoCompliance certificate for the quarter ended March 31 2026
4 months agoClosure of trading window
5 months agoOutcome of Board Meeting
5 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Office No.306, Shreenath Enclave Sr No.609/1 Part, Plot No. 6 7 8 Shreehari Kute Marg Nr, Samdeep Hotel, Mumbai Naka, Tidke Colony Nashik Maharashtra PIN: 422002 Tel No: 09167469649 Fax No: NULL Email: [email protected] Internet: www.rubramed.com
Registrars
G 10 Left Wing Amruta Village , Opp: Yashoda Hospital,Raj Bhavan Road,Somajiguda,Hyderabad G 10 Left Wing Amruta Village , Opp: Yashoda Hospital Raj Bhavan Road Somajiguda PIN: Tel No: NULL Fax No: NULL Email: NULL
Management
Shubham Chaudhary, Managing Director & Chief Financial Officer
Artee Sahu, Company Secretary & Compliance Officer
Gunjan Gangwal, Non Executive Independent Director
Gaurav Kaushik, Non Executive Independent Director
Ashish Jain, Non Executive Independent Director
Details
BSE 531099
NSE NULL
ISIN INE396H01019